Senseonics Holdings, Inc. (SENS) Stock Analysis
Recovery setup
Healthcare · Medical Devices
Sell if holding. Engine safety override at $8.90: Quality below floor (3.8 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.0/10 and A.R:R 2.1:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 12%; Below-average business quality.
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL,... Read more
Sell if holding. Engine safety override at $8.90: Quality below floor (3.8 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.0/10 and A.R:R 2.1:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 12%; Below-average business quality. Chart setup: Death cross but MACD improving, RSI 87. Score 6.0/10, moderate confidence.
Passes 8/9 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 76d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.
Recent developments
updated 2026-08-20Recent Developments — Senseonics Holdings, Inc.
Latest news
- NEWS Coty Posts Mixed Q4 Results, Joins Wolfspeed, ATRenew And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session — benzinga Aug 20, 2026 neutral
- NEWS Jim Cramer Says Buy Carpenter Technology, Calls This IT Services Stock a 'Value Trap' — benzinga Aug 14, 2026 neutral
Generated 2026-08-20T15:17:38Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
4 floor-breakers·1 ceiling hit
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static
Unprofitable operations — net margin -225.3%. Quality floor flags this regardless of sector context.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $8.90: Quality below floor (3.8 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.0/10 and A.R:R 2.1:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 12%; Below-average business quality. Chart setup: Death cross but MACD improving, RSI 87. Prior stop was $8.24. Score 6.0/10, moderate confidence.
Take-profit target: $11.66 (+31.6% upside). Prior stop was $8.24. Stop-loss: $8.24.
Quality below floor (3.8 < 4.0).
Senseonics Holdings, Inc. trades at a P/E of N/A (forward -4.7). TrendMatrix value score: 6.8/10. Verdict: Sell.
13 analysts cover SENS with a consensus score of 3.8/5. Average price target: $13.
What does Senseonics Holdings, Inc. do?Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of...
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.